[Teduglutide in short bowel syndrome]
Donato M, Ciapponi A, Alfie V, Rojas C, Klappenbach R, Bardach A, Augustovski F, Garcia Marti S, Alcaraz A, Pichon Riviere A
Record ID 32018002312
Spanish
Original Title:
Teduglutida en sÃndrome de intestino corto
Authors' recommendations:
Low-quality evidence suggests that the use of teduglutide in parenteral nutrition-dependent patients with short bowel syndrome and subsequent intestinal failure over-one-year-old might significantly reduce parenteral support requirements at medium term. However, the use of teduglutide did not show improvement in the nutritional status of pediatric patients and showed a significantly higher rate of serious adverse events (most of them gastrointestinal) and treatment discontinuation versus the standard of care.
Details
Project Status:
Completed
Year Published:
2021
URL for published report:
https://www.iecs.org.ar/publicacion/?id=20432
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Short Bowel Syndrome
- Gastrointestinal Agents
- Parenteral Nutrition
- Peptides
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.